This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Why Rockwell Medical (RMTI) Outpaced the Stock Market Today
by Zacks Equity Research
Rockwell Medical (RMTI) closed the most recent trading day at $1.95, moving +1.04% from the previous trading session.
Rockwell Medical (RMTI) Suffers a Larger Drop Than the General Market: Key Insights
by Zacks Equity Research
The latest trading day saw Rockwell Medical (RMTI) settling at $1.58, representing a -1.25% change from its previous close.
Rockwell Medical (RMTI) Stock Moves -1.18%: What You Should Know
by Zacks Equity Research
Rockwell Medical (RMTI) closed at $1.68 in the latest trading session, marking a -1.18% move from the prior day.
Why Rockwell Medical (RMTI) Dipped More Than Broader Market Today
by Zacks Equity Research
The latest trading day saw Rockwell Medical (RMTI) settling at $1.97, representing a -0.51% change from its previous close.
Rockwell Medical (RMTI) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Rockwell Medical (RMTI) closed at $2.06 in the latest trading session, marking a +1.48% move from the prior day.
Rockwell Medical (RMTI) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Rockwell Medical (RMTI) closed at $1.85, marking a +1.09% move from the previous day.
Rockwell Medical (RMTI) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Rockwell Medical (RMTI) closed the most recent trading day at $1.92, moving +1.05% from the previous trading session.
Rockwell Medical (RMTI) to Post Q2 Earnings: What's in Store?
by Zacks Equity Research
Robust product demand and cost-saving initiatives are likely to have boosted Rockwell Medical's (RMTI) second quarter's top line.
Leafly Holdings, Inc. (LFLY) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Leafly Holdings, Inc. (LFLY) delivered earnings and revenue surprises of 55.56% and 1.35%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Will Cresco Labs Inc. (CRLBF) Report Negative Q2 Earnings? What You Should Know
by Zacks Equity Research
Cresco Labs Inc. (CRLBF) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
PetIQ (PETQ) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
PetIQ (PETQ) delivered earnings and revenue surprises of 76.92% and 14.72%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
VAREX IMAGING (VREX) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
VAREX IMAGING (VREX) delivered earnings and revenue surprises of 12.12% and 1%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Rockwell Medical (RMTI) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Rockwell Medical (RMTI) closed the most recent trading day at $3.54, moving +1.43% from the previous trading session.
3 Reasons to Buy PCOR, OC and RMTI
by Sejuti Banerjea
Earnings season is the best time to make quick gains with any cash you may have to spare.
Rockwell Medical (RMTI) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Rockwell Medical (RMTI) closed at $4.03, marking a -0.74% move from the previous day.
Best Momentum Stocks to Buy for July 12th
by Zacks Equity Research
RMTI, ZUO and OPK made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on July 12, 2023.
New Strong Buy Stocks for July 12th
by Zacks Equity Research
SOHO, PD, RMTI, TEF and ZUO have been added to the Zacks Rank #1 (Strong Buy) List on July 12, 2023.
Rockwell Medical (RMTI) Soars 20.0%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Rockwell Medical (RMTI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
What Makes Rockwell Medical (RMTI) a Good Fit for 'Trend Investing'
by Zacks Equity Research
If you are looking for stocks that are well positioned to maintain their recent uptrend, Rockwell Medical (RMTI) could be a great choice. It is one of the several stocks that passed through our "Recent Price Strength" screen.
Bruker (BRKR) Introduces the D6 PHASER Benchtop XRD Platform
by Zacks Equity Research
Bruker's (BRKR) new D6 PHASER platform is to be used for material analysis and advanced research.
What Makes Rockwell Medical (RMTI) a Strong Momentum Stock: Buy Now?
by Zacks Equity Research
Does Rockwell Medical (RMTI) have what it takes to be a top stock pick for momentum investors? Let's find out.
Haemonetics (HAE) Gets FDA Clearance for NexSys PCS Upgrades
by Zacks Equity Research
Haemonetics (HAE) receives FDA clearance for the advancements made to the NexSys PCS plasma collection system.
Beat the Market Like Zacks: NVIDIA, VirTra, Rockwell Medical in Focus
by Abhinab Dasgupta
Our time-tested methodologies were at work to help investors navigate the market well last week. Here are some of our key performance data from the past three months.
Why Fast-paced Mover Rockwell Medical (RMTI) Is a Great Choice for Value Investors
by Zacks Equity Research
Rockwell Medical (RMTI) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Despite Fast-paced Momentum, Rockwell Medical (RMTI) Is Still a Bargain Stock
by Zacks Equity Research
Rockwell Medical (RMTI) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.